Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 940 clinical trials in Hoofddorp, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study of Epcoritamab for Patients with Relapsed, Progressive, or Refractory B-Cell Lymphoma
The NetherlandsStudy on Dapagliflozin for Patients with Severe Chronic Kidney Disease to Improve Kidney and Heart Health Outcomes
The NetherlandsStudy of Amivantamab, Lazertinib, and Drug Combination for Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer After Osimertinib Failure
The NetherlandsStudy on the Safety and Effectiveness of Ocrelizumab vs. Fingolimod for Children and Adolescents with Relapsing-Remitting Multiple Sclerosis
The NetherlandsStudy of Bosutinib for Children with Newly Diagnosed or Resistant Chronic Myeloid Leukemia
The NetherlandsStudy on Nipocalimab for Adults with Warm Autoimmune Hemolytic Anemia
The NetherlandsStudy on the Effectiveness and Safety of Remibrutinib Compared to Placebo and Omalizumab in Adults with Chronic Spontaneous Urticaria Uncontrolled by Antihistamines
The NetherlandsStudy of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease
The NetherlandsStudy of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
The NetherlandsStudy of Elranatamab, Dexamethasone, and Diphenhydramine Hydrochloride for Patients with High-Risk Smoldering Multiple Myeloma
The NetherlandsStudy Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments
The NetherlandsStudy of Rilzabrutinib for Adults with Relapsed Immune Thrombocytopenia
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on various cancer types including breast cancer, bladder cancer, and melanoma. Studies are evaluating novel treatment combinations and maintenance therapies for improved patient outcomes.
Multiple trials are investigating innovative approaches for both solid tumors and blood cancers, with particular emphasis on targeted therapies.
Comprehensive studies examining treatments for various blood disorders, including chronic myeloid leukemia, myelofibrosis, and lymphomas. Focus on developing targeted therapies and combination treatments.
Research aims to improve treatment outcomes and quality of life for patients with blood disorders.
Research initiatives addressing obesity management and surgical conditions like appendicitis. Studies include weight management therapies and surgical technique improvements.
Trials focus on both therapeutic and surgical interventions for better patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
